Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 79.11B | 79.11B | 81.89B | 74.10B | 69.12B | 69.80B |
Gross Profit | 12.50B | 12.50B | 12.31B | 9.59B | 10.71B | 11.05B |
EBITDA | 7.11B | 7.12B | 4.37B | 3.37B | 4.90B | 6.88B |
Net Income | 328.00M | 329.00M | -790.00M | -2.31B | -623.00M | 1.36B |
Balance Sheet | ||||||
Total Assets | 67.56B | 67.56B | 69.04B | 69.38B | 66.79B | 69.46B |
Cash, Cash Equivalents and Short-Term Investments | 14.78B | 14.78B | 14.50B | 12.22B | 10.55B | 12.71B |
Total Debt | 25.69B | 25.69B | 26.59B | 26.28B | 23.98B | 24.03B |
Total Liabilities | 46.12B | 46.12B | 49.97B | 50.13B | 45.18B | 48.31B |
Stockholders Equity | 18.76B | 18.76B | 16.45B | 16.79B | 19.38B | 19.02B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.74B | 2.28B | -401.00M | -1.79B | 603.00M |
Operating Cash Flow | 0.00 | 4.66B | 6.57B | 3.04B | 2.19B | 4.26B |
Investing Cash Flow | 0.00 | -3.14B | -3.76B | -3.63B | -4.38B | -3.10B |
Financing Cash Flow | 0.00 | -1.91B | -59.00M | 1.88B | -684.00M | -148.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥5.17B | 7.82 | 4.71% | 3.02% | 0.05% | 9.31% | |
76 Outperform | ¥3.07B | 8.78 | 3.37% | 3.00% | 1.42% | -20.24% | |
66 Neutral | ¥4.22B | 7.34 | 3.77% | 4.15% | 4.93% | ― | |
63 Neutral | ¥3.56B | 11.03 | ― | ― | -4.36% | ― | |
54 Neutral | ¥4.87B | -9.87 | -2.24% | 4.37% | 4.74% | -193.39% | |
39 Underperform | ¥3.33B | -0.62 | ― | ― | 13.02% | 15.34% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |